Gossamer Bio, Inc. — Director's Dealing 2023

Mar 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2023-03-20

Reporting Person: Carter Laura (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-20	Stock Option (Right to Buy)	$1.21	A	157500	Acquired	2033-03-19	Common Stock (157500.0)	Direct

Footnotes

F1: 25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.